208 related articles for article (PubMed ID: 19724845)
1. Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer.
Nakamura J; Kitajima Y; Kai K; Mitsuno M; Ide T; Hashiguchi K; Hiraki M; Miyazaki K
Oncol Rep; 2009 Oct; 22(4):693-9. PubMed ID: 19724845
[TBL] [Abstract][Full Text] [Related]
2. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in gastric carcinoma].
Wu Q; Li ZS; Li DW; Peng ZH; Yang ZR
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):498-501. PubMed ID: 19742344
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas.
Mizokami K; Kakeji Y; Oda S; Irie K; Yonemura T; Konishi F; Maehara Y
J Surg Oncol; 2006 Aug; 94(2):149-54. PubMed ID: 16847924
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
Oh SY; Kwon HC; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim CO; Kim SJ; Jeong JS; Kim HJ
BMC Cancer; 2008 May; 8():123. PubMed ID: 18452596
[TBL] [Abstract][Full Text] [Related]
8. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer.
Isobe T; Aoyagi K; Koufuji K; Shirouzu K; Kawahara A; Taira T; Kage M
Int J Clin Oncol; 2013 Apr; 18(2):293-304. PubMed ID: 22350022
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance.
Xuan Y; Wang YN
J Dig Dis; 2017 Sep; 18(9):511-520. PubMed ID: 28608600
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):905-8. PubMed ID: 17953839
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
Kolev Y; Uetake H; Takagi Y; Sugihara K
Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of Jumonji domain containing protein 2C and hypoxia-inducible factor-1α in gastric carcinoma and their clinical significance].
Xu Y; Yao HB; Jin Y; Ma YY; Wang HJ; Shao QS
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3375-8. PubMed ID: 24418035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]